@n41g7ng4t
The White House hopes a new cash-pay platform for popular GLP-1 drugs will lower U.S. prices.
It aims to pressure major drug companies directly.
The goal is to cut out the middlemen who inflate costs.
This move bets on market competition to make treatments more affordable.
0 reply
0 recast
0 reaction